Abstract:Telomerase activity is detected in more than 90% of examined tumors but not in most normal somatic cells. Among three subunits of human telomerase, human telomerase reverse transcriptase (hTERT) is the rate-limiting component for telomerase activity. Therefore, targeting hTERT represents a promising approach for diminishing telomerase function that will probably not cause substantial side effects on telomerase negative somatic cells. To explore the effects of antisense hTERT (ahTERT) on the malignant phenotypes of human SGC-7901 gastric cancer cell line in vitro, an antisense eukaryotic expression vector of hTERT was constructed by gene recombinant technology. Telomerase activity by telomeric repeat amplification protocol-ELISA, mRNA of telomerase subunits, c-myc and bcl-2 by reverse transcript-PCR, terminal restriction fragment (TRF) by Southern blot, cell cycle distribution by flow cytometry and protein expression of hTERT, c-myc and bcl-2 by Western blot were analyzed in SGC-7901 cells before and after transfection. Cloning efficiency assay in soft agar and tumorigenesis in nude mice were also examined and evaluated in the above cells. The results demonstrated that after ahTERT transfection, the proliferation of SGC-7901 cells was significantly inhibited. Further study showed that telomerase activity, telomere length, the mRNA and protein expression of hTERT, bcl-2 and c-myc were decreased in ahTERT-transfected cells. There were, however, no obvious effects on transcription of human telomerase RNA (hTR) and human telomerase associated protein1 (TP1) in both transfected and untransfected cells. Flow cytometric analysis displayed an accumulation of G(0)/G(1) phase and a decreasing proliferation index (131) in ahTERT-transfected cells. Moreover, no tumorigenicity was found after subcutaneous injection of ahTERT-transfected cells in nude mice, whereas palpable tumors were observed in mice injected with control cells. Our study indicates that exogenous ahTERT can inhibit proliferation and partially reverse malignant phenotypes of SGC-7901 cells via the suppression of telomerase activity, hTERT, c-myc and bcl-2 expression. Antisense technology targeted hTERT strategy might be a potential approach for gastric cancer therapy.

Reversing Malignant Phenotypes of Liver Cancer Cell Lines with Antisense Gene to Human Telomerase Reverse Transcriptase

Inhibiting Effect of Antisense Htrt on Telomerase Activity of Human Liver Cancer Cell Line SMMC-7721

Stable Expression of Antisense Htr Inhibits in Vitro Pancreatic Cancer Cell Growth.

Effect of antisense human telomerase RNA on malignant phenotypes of gastric carcinoma.

Effect of antisense gene to human telomerase reverse transcriptase on telomerase activity and expression of apoptosis-associated gene

Antisense Htert Inhibits Thyroid Cancer Cell Growth.

Inhibition of Human Telomerase in MKN-45 Cell Line by Antisense Htr Expression Vector Induces Cell Apoptosis and Growth Arrest

Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.

Antisense Human Telomerase RNA Mediated Inhibition of Telomere and Telomerase Activity in Human Gastric Cancer Cells

Delivering Antisense Telomerase RNA by a Hybrid Adenovirus/ Adeno-Associated Virus Significantly Suppresses the Malignant Phenotype and Enhances Cell Apoptosis of Human Breast Cancer Cells

Can Inhibition of Telomerase Increase Pancreatic Cancer Cell's Susceptibility to Chemotherapeutic Reagents?

Antisense Oligonucleotide Targeting at the Initiator of Htert Arrests Growth of Hepatoma Cells.

[Inhibition of Growth and Proliferation of Hep-2 Cells by Targeting Human Telomerase Reverse Transcriptase Mrna Using RNA Interference Technology].

Primary study on effects of telomerase antisense RNA on human HCC HepG2 cells

The antisense gene of growth factor receptor reversing the malignant phenotype of human hepatoma cells

Inhibition to hepatoma cells by anti-sense RNA targeting the key site of hTERT gene

[Targeted Therapy of Human Laryngeal Squamous Cell Carcinoma in Vitro with Telomerase Catalytic Subunit Mrna].

Inhibition of Human Telomerase Reverse Transcriptase in Hep-2 Cells Using Short Hairpin RNA Expression Vectors

hTR gene cloning from human gastric cancer cells and the construction of its sense and antisense eukaryotic expression vector

Antitumor Efficacy of Human Telomerase Reverse Transcriptase Gene Antisense Oligonucleotide in Pancreatic Cancer Cells.

Effect of Htert Antisense Gene on Telomerase Activity in Human Tongue Cancer Cells